TwitterLinkedInYouTubeslideshareflickrIFPMA - Global Health Matters - BlogRSS
IFPMA Home

International Federation of Pharmaceutical Manufacturers & Associations





IFPMA at the Geneva Health Forum

15 April 2014, Geneva, Switzerland

EVIDENCE INFORMED DECISION MAKING IN ACHIEVING UNIVERSAL HEALTH COVERAGE (UHC): THE ROLE OF MACRO HEALTH TECHNOLOGY ASSESSMENT (HTA)


12:15 - 13:45
CICG, Room 3 LUNCH SESSION

This session will explore the role of evidence informed decision making in achieving Universal Health Coverage, looking specifically at the role of "macro" Health Technology Assessment as it is applied to overall health system eciency and quality of care. This unique session will provide you with a view of different perspectives from various sectors in the healthcare space - patient, industry, and academic. A graphic recorder will provide participants with valuable visual, colorful and engaging information.

Speakers:

  • Eva Maria Ruiz de Castilla, PhD, Executive Director, Esperantra (NPO, Peru)
  • Adrian Griffin, Vice President, HTA Policy, Johnson & Johnson
  • Franz Pichler, PhD., Director, Global Public Policy, Eli Lilly and Company
  • John-Arne Rottingen, Division of Infectious Disease Control at the Norwegian Institute of Public Health

Moderated by:

  • Nick Drager M.D., Ph.D., Honorary Professor, Senior Fellow, Global Health Programme, The Graduate Institute, Geneva


RSVP to info@ifpma.org
You will be requested to present this invitation
at entrance. A pass for the Geneva Health
Forum is not required to attend this session.

Lunch boxes are available to all session participants.

Events
Resources

UPDATED! Developing World Health Partnerships Directory

The research-based pharmaceutical industry engages in a wide range of public-private partnerships...

IFPMA Code of Practice

Expanded IFPMA Code of Practice updates ethical and professional standards for interacting with...

Interview Series

The IFPMA Interview Series is a video library of interviews with people from different walks of...